Institutes of Health. DBA/2 mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. Serum samples were obtained immediately before and 6 d after intraperitoneal administration of 50 #g LPS (lipopolysaccharide B, Escherichia coli 0111: B4; Difco Laboratories, Detroit, Mich.).
Serum lsotype Analysis. Levels of IgM, IgA, IgG 1, IgG2a, IgG2b, and IgG3 immunoglobulins in individual mouse sera were determined by using a solid-phase inhibition type radioimmunoassay performed in microtiter plates (Cooke Laboratory Products Div., Dynatech Laboratories, Alexandria, Va.) as previously described (11) . Specific antisera used in these assays were prepared in rabbits by immunization with mouse myeloma proteins and were rendered at least 100-fold specific by appropriate absorption with myeloma proteins of other isotypes as described before (11) .
Anti-y3 was prepared by immunizing a rabbit with 250 lag of FLOPC-21 protein (y3, K; Litton Bionetics, Inc., Kensington, Md.) in complete Freund's adjuvant (CFA) i.p.; 1 mo later the animal was boosted with 600 lag of W5606 ('/3, X) in CFA and bled 1 mo later. The serum was absorbed with a Sepharose conjugate of the globulin fraction of serum from an MPC-11 ('/2b, K) bearing mouse. When used in the radioimmunoassay at 1:8,000 dilution, maximum binding of x25I-J606 ('/3, K) was 15-30%. Inhibition of binding by myeloma proteins showed at least 1,000-fold specificity for IgG3 compared to all other isotypes.
lsotype-Specific Plaque-Forming Cell (PFC) Enumeration. Spleen cells secreting IgM and IgG3 immunoglobulins were detected by a modified hemolytic plaque assay (13) by using staphylococcal protein A-derivatized sheep erythrocytes (SRBC) and our isotype-specific rabbit antisera. Specificity of this assay system was verified by using a panel of mouse myeloma cells secreting each of the major mouse isotypes. Up to 60% of J606 and M104 myeloma cells formed plaques when tested with anti-'/3 and anti-la antisera, respectively. However, essentially no plaques were observed with these reagents when tested against myelomas secreting any other isotype, even at cell densities of 1 × l0 s per slide.
Results and Discussion Table I shows the IgG3 concentrations in nonimmune sera derived from CBA/N, DBA/2, and their hybrids. Both CBA/N male and female mice show exceedingly low circulating levels of IgG3, near the limits of detection. In contrast, DBA/2 and (DBA/ 2 × CBA/N)Fx males, both of which possess the DBA/2 X chromosome and which do not therefore express the CBA/N defect, have relatively high levels of IgG3, approaching 200/~g/ml in 14-mo-old mice. (CBA/N × DBA/2)F1 males, that are hemizygous for the defective CBA/N × chromosome, behave much like the homozygous CBA/N mice and show low base-line levels of circulating IgG3. Even older individuals fail to express more than 20 ~g/ml of IgG3 antibodies.
It has not been possible thus far to generate a radioimmunoassay for mouse IgG3 with >l,000-fold specificity. Thus, serum levels of IgG3 less than 5/~g/ml cannot be measured because of cross-reactivity of other isotypes with the anti-y3 reagent. To distinguish between low levels of IgG3 and a total absence of IgG3 in mice bearing the CBA/N defect, stimulation of IgG3 secretion was attempted by using LPS immunization. LPS is believed to stimulate B-cell proliferation and antibody secretion relatively nonspecifically (14) . . A more precise method of evaluating immunoglobulin production is to determine the number of cells secreting the various isotypes. Fig. 2 shows the number of spleen ceils secreting IgM and IgG3 in unstimulated and LPS-stimulated defective and nondefective mice. The deficiencies seen before in serum levels of these isotypes are reflected by comparable deficiencies of isotype-secreting cells. Although there are no detectable IgG3-secreting cells in unstimulated CBA/N or (CBA/N × DBA/2)F1 male mouse spleens, LPS does stimulate significant responses. However, although the anti-,/3 facilitating serum is highly specific for isotype in the reverse plaque assay, it is more difficult to evaluate specificity for variable region determinants, because the panel of myelomas used to evaluate specificity must of necessity express limited variable region determinants.
Restriction of the CBA/N defect to IgM and IgG3 isotypes might be explained by arguing that the environmental antigens that are normally responsible for stimulation of persistent serum IgM and IgG3 titers are mainly bacterial carbohydrates, antigens to which CBA/N mice are unresponsive. Thus, the CBA/N immunodeficiency may not directly affect the appearance of IgG3-bearing B lymphocytes; the observed low circulating levels oflgM and IgG3 might simply reflect the range of antigens to which the CBA/N mouse is unresponsive. Alternatively the central defect in the CBA/N mouse strain might be a selective deficiency in stimulable ceils committed to the production of IgM and IgG3.
On the other hand, the fact that LPS treatment of mice with the CBA/N defect does not completely repair their deficiency in IgG3 is not evidence that the rate of appearance of lymphocytes that are precursors of IgG3 secreting cells is abnormal in these mice. It is quite likely that environmental stimulation with polysaccharide antigens normally causes an expansion in IgG3 precursors, whereas cells from immune Serum isotype levels in (DBA/2 X CBA/N)F] and (CBA/N X DBA/2)F] male mice. Serum was collected before and 6 d after LPS stimulation of groups of four to six defective and nondefective mice. Upper panels: isotype levels in serum as determined by radioimmunoassay. Lower panels: relative concentration (defective compared to nondefective mice) of each isotype before and after LPS stimulation. The relative amounts of IgM and IgG3 in the serum of normal and defective mice 4 and 8 d after LPS treatment were similar to those at 0 and 6 d. It should be noted that the IgG3 levels in unstimulated mice of both phenotypes are higher here than those shown in Table I . We have found a consistent difference in IgG3 levels in animals maintained in different facilities, which probably reflects different environmental stimulants. H, nondefective (DXC); 0-----0, defective (CXD); I, before LPS, o, 6 d after LPS. defective mice, because they are unresponsive to such antigens, fail to undergo a similar environmental antigen-driven expansion. Indeed, contact of IgG3 precursors from defective mice with environmental polysaccharides may actually induce tolerance in these cells (16) . In either case, mice with the CBA/N defect would appear to have diminished numbers of precursors of IgG3-secreting cells when compared to normal individuals. LPS stimulation, although it would increase their absolute IgG3 levels should not change their expression of this isotype relative to similarly treated normal controls.
Finally, it is interesting to speculate on the mechanism by which the responses to bacterial polysaccharides and certain related antigens might be largely confined to the IgM and IgG3 classes. We have previously demonstrated that many bacterial carbohydrate antigens elicit antibody responses in the mouse largely restricted to IgG3 (11) . Our attempts to alter this subclass-restriction by carrier manipulation have been unsuccessful (11) . This suggests that certain Vn regions are only expressed in the context of certain Ca regions. Inability to elaborate IgG3, perhaps a subclass (as yet unidentified) of IgM, and the Vn regions that are ordinarily linked to these Cn genes might either explain the complex immunodeficiency of the CBA/N mouse or be an important consequence of a primary inability to respond to polysaccharide antigens.
Summary CBA/N mice express an X-linked deficiency in their antibody response to many bacterial carbohydrates; we have shown recently that these antigens normally elicit antibody responses predominantly of the IgM and IgG3 isotypes. Here we demonstrate that mice with the CBA/N phenotype have preferential deficiencies of IgM and IgG3 immunoglobulin expression, both when measured in serum and in cells secreting these isotypes, and that this deficiency is only partially corrected by polyclonal activation of B cells. This suggests that CBA/N mice may lack a subpopulation of B cells that contains most of the IgG3 precursors.
